Generic Name and Formulations:
Purified water, MultiSal Neolipids*, glyceryl stearate, squalane, glycerin, PEG-100 stearate, hydroxypropyl bispalmitamide MEA (ceramide), petrolatum, dimethicone, phenoxyethanol, cholesterol, conjugated linoleic acid, citric acid, palmitic acid, xanthan gum, potassium hydroxide, disodium EDTA, sorbic acid, capric acid; controlled-release skin barrier emulsion; steroid-, fragrance-free. *Proprietary microencapsulation system for gradual delivery of key ingredients including ceramide, conjugated linoleic acid,cholesterol and palmitic acid (formulated with E.Cerifera [Candelilla] wax, corn syrup solids and modified food starch).
Indications for EPICERAM:
To treat dry skin conditions and to manage and relieve burning and itching associated with various types of dermatoses, including atopic dermatitis, irritant contact dermatitis, and radiation dermatitis.
Adults and Children:
Apply thin layer to affected areas 2 times per day (or as needed). Massage gently into skin. If skin is broken, cover with dressing. Apply following radiation therapy.
Reevaluate if no improvement within 10–14 days. Use in conjunction with sunscreen in sun exposed areas.
Do not apply within 4hrs prior to radiation therapy.
Tingling sensation at application site.
Emulsion—90g (tube); 100g, 225g (airless pump); 400g (Quad Pack: 4×100g airless pumps)
Clinical Pain Advisor Articles
- History of Migraine May Be Associated With Higher Risk for Cochlear Disorders
- Radiofrequency Denervation Efficacious in Treating Thoracic Zygapophyseal Joint Pain
- Symptom Severity, Sensory Sensitivity May Indicate Pain Centralization in Chronic Overlapping Pain Conditions
- Prescribed Opioids Difficulties Scale Effective for Assessing Concerns of Patients With Chronic Pain
- Predictors of Opioid Overdose in High-Risk Users
- Consensus Guidelines for the Use of Intravenous Ketamine for Chronic Pain
- Pain Societies Issue Guidelines on Use of Ketamine for the Management of Acute Pain
- Labor Epidural Analgesia Linked to Reduced Likelihood of Successful Breastfeeding
- Novel Oral Treatment Safe, Effective for Migraine Headache Relief
- DFN-02 Nasal Spray Safe, Effective for Acute Treatment of Episodic Migraine
- Higher PainDETECT Scores, Neuropathic Pain Preoperatively May Increase Risk for Chronic Pain Post-TKR
- Terms Used for Addiction May Be Associated With Explicit, Implicit Bias
- Erenumab Reduces Monthly Migraine Days in Patients With Treatment-Resistant Migraine
- Government and Industry Lead the Way in Funding USPSTF Systematic Reviews
- Communication-Based Intervention Increases Goals-of-Care Discussions Between Physicians, Patients With Serious Illness